| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue | 17 | 98 | 109 | 27 | | Cost of Revenue | 11 | 63 | 49 | 3 | | | Gross Profit | 6 | 34 | 60 | 24 | | | Operating Expenses | | Research Development | 1,224 | 415 | 626 | 2,159 | | Selling General and Administrative | 547 | 472 | 647 | 1,735 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 45 | 45 | 45 | 45 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,810) | (898) | (1,259) | (3,915) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 0 | 0 | 0 | 2 | | Earnings Before Interest And Taxes | (1,810) | (898) | (1,259) | (3,913) | | Interest Expense | 429 | 778 | 558 | 492 | | Income Before Tax | (2,239) | (1,676) | (1,816) | (4,406) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,239) | (1,676) | (1,816) | (4,406) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,239) | (1,676) | (1,816) | (4,406) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,239) | ($1,676) | ($1,816) | ($4,406) |
|
0.34% Nasdaq 
Income Statement
